ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Needed Enhancement Or Unfunded Mandate? New NCI Program To Merge CCOP, NCCCP

July 13, 2012

Study Section Members Likelier to Be Funded

August 1, 1986

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014